Design of a disulfide-less, pharmacologically inert, and chemically competent analog of maurocalcine for the efficient transport of impermeant compounds into cells.
2008
Ram, Narendra | Weiss, Norbert | Texier-Nogues, Isabelle | Aroui, Sonia | Andreotti, Nicolas | Pirollet, Fabienne | Ronjat, Michel | Sabatier, Jean-Marc | Darbon, Hervé | Jacquemond, Vincent | de Waard, Michel | Grenoble Institut des Neurosciences | Université Joseph Fourier - Grenoble -Institut National de la Santé et de la Recherche Médicale | Physiologie intégrative, cellulaire et moléculaire | Université Claude Bernard Lyon | Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique | Commissariat à l'énergie atomique et aux énergies alternatives - Laboratoire d'Electronique et de Technologie de l'Information | Direction de Recherche Technologique | Commissariat à l'énergie atomique et aux énergies alternatives -Commissariat à l'énergie atomique et aux énergies alternatives | ERT Ambrilia Biopharma S.A. | Université de la Méditerranée - Aix-Marseille | Architecture et fonction des macromolécules biologiques | Institut National de la Recherche Agronomique -Aix Marseille Université -Centre National de la Recherche Scientifique | Inserm | Fonds de valorisation du Commissariat à l'Energie Atomique | Région Rhône-Alpes bourse Emergence pour doctorant
International audience
Show more [+] Less [-]English. Maurocalcine is a 33-mer peptide initially isolated from the venom of a Tunisian scorpion. It has proved itself valuable as a pharmacological activator of the ryanodine receptor and has helped the understanding of the molecular basis underlying excitation-contraction coupling in skeletal muscles. Because of its positively charged nature, it is also an innovative vector for the cell penetration of various compounds. We report a novel maurocalcine analog with improved properties: (i) the complete loss of pharmacological activity, (ii) preservation of the potent ability to carry cargo molecules into cells, and (iii) coupling chemistries not affected by the presence of internal cysteine residues of maurocalcine. We did this by replacing the six internal cysteine residues of maurocalcine by isosteric 2-aminobutyric acid residues and by adding an additional N-terminal biotinylated lysine (for a proof of concept analog) or an N-terminal cysteine residue (for a chemically competent coupling analogue). Additional replacement of a glutamate residue by alanyl at position 12 further improves the potency of these analogues. Coupling to several cargo molecules or nanoparticles are presented to illustrate the cell penetration potency and usefulness of these pharmacologically inactive analogs.
Show more [+] Less [-]Bibliographic information
This bibliographic record has been provided by National Institute for Agricultural Research